• Mon, December 7, 2015
  • Tue, December 8, 2015
  • Wed, December 9, 2015
  • Thu, December 10, 2015
  • Fri, December 11, 2015
  • Mon, December 14, 2015

Matthew Harrison Downgraded (BLUE) to Hold and Decreased Target to $69 on, Dec 7th, 2015

Matthew Harrison of Morgan Stanley, Downgraded "bluebird bio, Inc." (BLUE) to Hold and Decreased Target from $143 to $69 on, Dec 7th, 2015.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Yanan Zhu of "Wells Fargo" Initiated at Buy on, Friday, December 4th, 2015
  • Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $165 on, Wednesday, November 18th, 2015
  • Mark Breidenbach of "Oppenheimer" Initiated at Buy and Held Target at $162 on, Tuesday, October 20th, 2015